The Effects of Types of Fruits and Vegetables on Vascular Function
NCT ID: NCT03410342
Last Updated: 2022-03-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
36 participants
INTERVENTIONAL
2017-09-04
2021-06-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Regular and Consequent Citrus Fruits Consumption on Vascular Protection
NCT00539916
Effects of Fruit Consumption on Risk Factors of Chronic Disease
NCT01963416
Impact of Oranges on Cardiovascular Health
NCT01935362
The Impact of Citrus Products on Cardiovascular Health
NCT03611114
Diet and Vascular Health Study
NCT01114399
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* 1 portion of fruits plus 1 portion of vegetables, of commonly consumed types per day. Intakes are at 25th percentile of UK consumption and will exclude citrus fruits, cruciferous and allium vegetables.
* 4 portions of fruits plus 4 portions of vegetables, of commonly consumed types per day excluding citrus fruits, cruciferous and allium vegetables.
* 4 portions of citrus fruits plus 4 portions of cruciferous vegetables per day.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low Fruits and Vegetables (LFV)
1 portion of fruits plus 1 portion of vegetables, of commonly consumed types per day.
Intakes are at 25th percentile of UK consumption (NDNS) and will exclude citrus fruits, cruciferous and allium vegetables.
LFV
1 apple/banana/small bunch of grapes per day plus 1 portion of carrot/pepper/tomato per day
High Fruits and Vegetables (HFV)
4 portions of fruits plus 4 portions of vegetables, of commonly consumed types per day excluding citrus fruits, cruciferous and allium vegetables.
HFV
4 portions of fruits (apples, bananas, grapes, pears) plus 4 portions of vegetables (carrots, cucumber, sweet peppers, tomatoes), of commonly consumed types per day excluding citrus fruits, cruciferous and allium vegetables.
High Citrus fruits and Cruciferous vegetables (CC)
4 portions of citrus fruits plus 4 portions of cruciferous vegetables per day excluding any other types of fruits and vegetables including allium vegetables.
CC
4 portions of citrus fruits (clementines, grapefruits, lemons, oranges) plus 4 portions of cruciferous vegetables (broccoli, brussels sprouts, cauliflower, kale, savoy cabbage) per day.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LFV
1 apple/banana/small bunch of grapes per day plus 1 portion of carrot/pepper/tomato per day
HFV
4 portions of fruits (apples, bananas, grapes, pears) plus 4 portions of vegetables (carrots, cucumber, sweet peppers, tomatoes), of commonly consumed types per day excluding citrus fruits, cruciferous and allium vegetables.
CC
4 portions of citrus fruits (clementines, grapefruits, lemons, oranges) plus 4 portions of cruciferous vegetables (broccoli, brussels sprouts, cauliflower, kale, savoy cabbage) per day.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Average systolic blood pressure of 125-140 mmHg at 2 measurements separated by \>30 minutes
* No use of antihypertensive medication
* No reported current or previous diabetes mellitus, (secondary) hypertension, or metabolic, cardiovascular, renal, liver, thyroid, gastrointestinal diseases
* Body Mass Index between 20 - 35 kg/m2
* Non-smoker
* Average fruit and vegetable consumption of \<4 portions per day (UK average, 40-65 years), or willing to reduce habitual daily fruit and vegetable intake.
Exclusion Criteria
* Excessive alcohol intake of \> 21 units per week (females) or \>28 units per week (male) and not willing to limit alcohol intake to maximum of 1 unit/day
* Physical activity of \>=10 hours/week of moderate to vigorous physical activity
* Weight loss or gain of \>=3 kg in the preceding 3 months
* Use of dietary supplements or unwilling to stop supplement use \>= 2 weeks before enrolment and during intervention
* Pregnancy or lactation
* Intervention specific factors, including:
* Unable or unwilling to consume provided diets during the intervention
* Unsufficient storage space for provided diets
* Food sensitivities or vegetarian/vegan diet by choice
* Participation in another intervention study at the same time
* Living \> 15 miles from the Imperial/NIHR Clinical Research Facility at Hammersmith Hospital
* No signed informed consent
40 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Imperial College London
OTHER
University of Cambridge
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Linda Oude Griep
Senior Research Associate
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Linda Oude Griep, PhD
Role: PRINCIPAL_INVESTIGATOR
MRC Epidemiology Unit, University of Cambridge
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cambridge Epidemiology & Trials Unit
Cambridge, , United Kingdom
Imperial/NIHR Clinical Research Facility
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Research Ethics Committee
Identifier Type: REGISTRY
Identifier Source: secondary_id
17HH3878
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.